Abstract:Abstract Background: SIPA1 (signal-induced proliferation-associated protein 1) encodes for a GTPase-activating protein, known to be a negative regulator of Ras-related Protein (RAP1). It has been implicated in cancer invasion and metastasis, including cervical cancer, breast cancer and colorectal cancer. In our previous study of SIPA1 activates the integrin beta1 to promote metastasis, we found that SIPA1 may effect series of surface adhesive protein expression, including an important glyco-protein, CD44. CD44 is reported as a critical marker of breast cancer stem cells, so we hypothesis that SIPA1 may induce the stemness in breast cancer through regulating the expression of CD44. Methods: We examined the relationship between the expression of SIPA1 and CD44 in breast cancer tissues and different breast cancer cell lines. Then we used the knockdown of SIPA1 in MDA-MB-231 and an overexpression in the MDA-MB-361 to examine the effects of SIPA1 expression to CD44 in breast cancer cell lines. In vitro tumorigenic properties of SIPA1 high cells were characterized with sensitivity to 5FU and the ability to form tumorspheres, the expression of cancer stem cell markers, including CD44, CD24, ALDH, and the proportion. In vivo analysis used a tissue microarray chip with clinicopathologic features and survival data from 240 breast cancer patients were reviewed with immunohistochemistry (IHC) against SIPA1. Results: In vitro studies showed that SIPA1 high cells with a high level of CD44 expression. They displayed an obviously EMT phenotype, and found to have a higher ability to form tumor spheres, improved expression level of breast cancer stem cell markers, increased resistance to 5FU, and decreased in the cell proliferation. SIPA1 may induce cancer stem cell features through the expression of CD44 and induced the EMT through CD44-PI3K-Akt pathway with a changed CD44 splicing isoform pattern. Studies with breast cancer tissues showed that SIPA1 expressed in the in situ breast cancer, while SIPA1 and CD44 are co-expressed in the metastasis breast cancer. The Kaplane-Meier survival analysis of 240 breast cancer samples found that SIPA1 negative-associated with breast cancer survive (p = 0.003) and prognosis (p = 0.002), and the Cox's proportianal hazard model analysis of prognostic factors in patients with potentially curatively treated breast cancer showed that SIPA1 expression correlated with 5 disease free survive(p = 0.047) and 5 year overall survive(p = 0.015). Conclusion: Taking together, our data suggest that SIPA1 induced CD44 expression in breast cancer cells, SIPA1/CD44high cells display stemness and EMT phenotype, and found to be more resistance to 5FU with a decreased proliferation ability. SIPA1 expression contributes to the survival and prognosis of breast cancer. Further studies to investigate how SIPA1 promotes CD44 expression are needed. Citation Format: Li Su, Jing Xia. SIPA1 negatively regulates the survive in breast cancer patients and promotes CD44 expression to drive cancer cell stemness. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2245. doi:10.1158/1538-7445.AM2015-2245

SIPA1 is a modulator of HGF induced tumour metastasis via the regulation of tight junctions in lung adenocarcinoma cells

SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7

Expression of Signal-Induced Proliferation-Associated Gene 1 (SIPA1), a RapGTPase-activating Protein, is Increased in Colorectal Cancer and Has Diverse Effects on Functions of Colorectal Cancer Cells.

SIPA1 Enhances Aerobic Glycolysis Through HIF-2α Pathway to Promote Breast Cancer Metastasis

Abstract 2245: SIPA1 Negatively Regulates the Survive in Breast Cancer Patients and Promotes CD44 Expression to Drive Cancer Cell Stemness

SIPA1 Enhances SMAD2/3 Expression to Maintain Stem Cell Features in Breast Cancer Cells.

Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells

Dynamic relationship between SIPA1 gene and protein expression and the development of gastric cancer.

Effect of SIPA1 on the Metastasis and Recurrrence of Hepatocellular Carcinoma

SIPA1 promotes epithelial-mesenchymal transition in colorectal cancer through STAT3 activation

A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer

SPHK1 Promotes HNSCC Immune Evasion by Regulating the MMP1-PD-L1 Axis

HPIP Silencing Inhibits TGF-β1-induced EMT in Lung Cancer Cells.

Hsg-Mlf1ip Axis As Potential Targets For Lung Adenocarcinoma Treatment.

SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells

The SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancer

Interaction Of S100a1 With Lats1 Promotes Cell Growth Through Regulation Of The Hippo Pathway In Hepatocellular Carcinoma

Elevated mRNA level indicates FSIP1 promotes EMT and gastric cancer progression by regulating fibroblasts in tumor microenvironment

Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton

The expression of SIPA1 in hepatocellular carcinoma and its prognostic significance

Paip1 Predicts Poor Prognosis and Promotes Tumor Progression Through AKT/GSK-3β Pathway in Lung Adenocarcinoma.